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ABSTRACT 
PROMOTING EXTRACELLULAR MATRIX CROSSLINKING IN SYNTHETIC HYDROGELS 
SEPTEMBER 2015 
MARCOS MATIAS MANGANARE, LIC. UNIVERSIDAD NACIONAL DE QUILMES 
M.S., UNIVERSITY OF MASSACHUSETTS AMHERST 
Directed by: Professor Shelly Peyton 
The extracellular matrix (ECM) provides mechanical and biochemical support to tissues and cells. It is of 
crucial importance for cell attachment, differentiation, and migration, as well as for ailment-associated 
processes such as angiogenesis, metastases and cancer development. An approach to study these 
phenomena is through emulation of the ECM by synthetic gels constructed of natural polymers, such as 
collagen and fibronectin, or simple but tunable materials such as poly(ethylene glycol) (PEG) crosslinked 
with short peptide sequences susceptible to the activity of metalloproteases and cell-binding domains. Our 
lab uses PEG gels to study cell behavior in three dimensions (3D). Although this system fosters cell 
attachment and crosslinking peptides susceptible to degradation by matrix metalloproteases (MMPs), the 
regenerative process of the ECM has not been mimicked yet in 3D synthetic gels. In an attempt to build in 
this functionality to PEG-based gels, I attempted to find short peptides that could be used as re-connectors 
of the matrix elements in order to emulate the in vivo reconstitution process. I performed phage display to 
identify short oligopeptides that bind either collagen or fibronectin to assess them as potential nucleation 
points for crosslinking. A phage display is a library of random oligopeptides expressed on a M13. This 
strategy allows identification of a phenotype and a genotype with a single screening step. In comparison 
with other techniques, such as antibodies or target-binding proteins, the phage display strategy could yield a 
short oligopeptide that would be more specific, would not depend on folding, and is inexpensive. I 
identified the conditions under which phage display is compatible with our targets, and I isolated and 
identified five peptide candidates for fibronectin binding and two for collagen. Future work include 
assessing  whether these candidates could facilitate the formation of cell-created crosslinking in 3D 
synthetic  hydrogels. 
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CHAPTER 1 
MIMICKING THE EXTRACELLULAR MATRIX AND ITS FUNCTIONS 
 
1.1 Introduction 
ECM-mimicking PEG-based hydrogels are useful to shed light upon cell behavior such as 
migration, metastasis and cell mechanosensing  (1, 2). Their potential applications in 
regenerative medicine are promising based on PEG’s relatively inert properties (3), and 
the fact that crosslinkers and proteins can be controllably added (3, 4). However, there 
are processes occurring in vivo on the ECM-cell dynamic interaction that have yet not 
been emulated in vitro, such as ECM reconstruction. Research toward finding new 
components that can be incorporated in the construction of these hydrogels in order to 
match these natural phenomena are needed. 
 
The operational hypothesis underlying this work, as a potential strategy to imitate the 
ECM reconstruction process, is that generating short molecules with binding affinity for 
3D PEG hydrogel components such as collagen and fibronectin will function as a 
crosslinking nucleation point. The objectives of this work are to 1) use a phage display to 
screen a peptide (7mers) library to find sequences with binding affinity for fibronectin 
and collagen, and 2) assess candidate efficacy in stabilizing and increasing the endurance 
of the PEG based hydrogels when challenged by the activity of MMPs. 
 
 
 
1 
9 
 
1.2 Specific Aims to generate Hydrogels Crosslinkers 
 
1.2.1  Aim 1: Use phage display to identify peptide candidates that bind to either 
collagen I or fibronectin.  
Hypothesis: By phage display I will find peptides able to bind to fibronectin or collagen 
for eventual use in PEG-based hydrogels. 
Method: I used a phage display Ph.D7 kit, which contains every possible 7mer peptide 
sequence (20
7
 peptides) and screened their affinity to our interest molecules (5). I first 
coated plates with either collagen or fibronectin. I used E. coli infected with the M13-
based phage library, increased the phage mass, purified the phages, and challenged them 
against the target molecule-coated plates. Then, by a double step panning process, I 
selected the high affinity phages. Phage colonies were isolated and their DNA sequenced.  
 
1.2.2 Aim 2: Synthetize, confirm, and purify candidate peptides. 
Hypothesis: I will successfully synthetize peptides identified in Aim 1. 
Method: Peptides identified in Aim 1 were synthesized, as well as two additional peptides 
found in the literature (6, 7). I plan to compare the binding capabilities of these published 
peptides with those identified in Aim 1. Peptides were synthesized by solid-phase 
methods in collaboration with the Perry lab. 
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 1.2.3 Aim 3: Test the potential applications of the isolated peptides as re-linkers in 
synthetic 3D matrices.   
Hypothesis: The affinity of the peptides obtained in Aim 1 for will facilitate cell-
mediated crosslinking. 
Method: We will prepare PEG hydrogels including phage display-identified peptides.  
Gels will otherwise contain the same components as typical in the Peyton lab (MMP-
degradable peptides and integrin binding peptides).  Cells will be seeded in the gels, and 
after 7 days gels of culture will be fixed, and ECM components detected by 
immunostaining.  We expect to see increased fibronectin and collagen staining in the 
appropriate peptide-containing gels.  Further, we expect to see reduced degradation in 
peptide-containing gels as compared to typical PEG gels. 
 
Through this work we expect that the peptides we found in Aim 1 will bind to collagen 
and fibronectin, will serve as nucleation points when added to PEG hydrogels, promoting 
the building up of ECM elements on the gels. This strategy will improve the PEG 
hydrogel tool bringing it a step closer toward the ultimate goal of developing self-healing 
synthetic hydrogels. 
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CHAPTER 2 
SIGNIFICANCE OF PROMOTING THE RECONSTRUCTION OF 
HYDROGELS NETWORKS IN VITRO 
 
2.1 Tissue engineering combines artificial structures, scaffolds, and cell factors to 
support cell culture. 
 Scaffolds for tissue engineering are designed to emulate the in vivo cell milieu, thus they 
must provide some natural functions. For example, they should allow for cell attachment 
and migration, as well as enable diffusion of cell nutrients and secreted cell products 
and/or delivery and retain cells and biochemical factors (8).  In order to do so, these 
scaffolds must reunite some requirements. They should be porous, and these pores should 
be of a proper size to be conducive to cell establishment and nutrient diffusion. They can 
also be biodegradable, and this biodegradability can facilitate cell behaviors such as 
migration and proliferation.  Hydrogels such as polyacrylamide (PAA)  and PEG (4) are 
some of the biomaterials suitable as scaffolds for tissue engineering due to their high 
water content, soft tissue-like consistency, and biocompatibility (9). Besides their 
eventual ex vivo applications, they are promising for their in vitro applications as model 
systems for studying cell proliferation, interaction, migration, adhesion, differentiation, 
and metastasis, within an emerging field known as mechanobiology (4). 
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2.2 PEG hydrogels exhibit many advantages compared to other synthetic hydrogels. 
PEG hydrogels are relatively bio-inert, they have low protein adsorption properties, are 
nontoxic and innocuous generating minimal inflammatory response, they are water 
soluble, and their reagents are readily available and economical. These characteristics 
make them highly desirable. Moreover, they are easily amenable to chemical 
manipulation, molecular chain length, weight percentage and cross-linking.  Furthermore, 
the process of gelation in PEG hydrogels can be performed under nontoxic conditions (3, 
8).  In comparison to matrices made of natural components such as collagen and 
fibronectin, PEG hydrogels exhibit the enormous advantage that bioactive functionalities 
such as cell anchorage sequences, cell degradable sequences, and growth factors can be 
added in a measurable and controllable amount to obtain desirable or favorable cell or 
tissue behavior (3, 10). In this way, synthetic PEG hydrogels containing components of 
ECM can chemically and physically mimic the ECM to some degree (10).  
 
2.3 PEG conjugated to maleimide forms gels more efficiently than other 
macromolecules. 
 Maleimide (MAL) groups conjugated to polyethylene glycol chains are used as flexible 
linking molecules to bind proteins to surfaces because of their fast reaction kinetics and 
affinity for thiols at physiological pH (3). The double bond of the maleimide group reacts 
with the thiol group of a cysteine, resulting in a carbon-sulfur bond. Compared with other 
bio-ligand macromolecules, such as 4-arm PEG acrylate (PEG 4A), 4-arm PEG 
vinylsulfone (PEG-4VS) or PEG diacrylate (PEG DA), gels made of PEG 4MAL 
incorporate the crosslinkers and the cell-adhesive RGD sequence more efficiently, are 
5 
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more efficient in gelation time, and have tighter structure. Moreover, with the low 
polymer weight percentage, PEG-4MAL can form gels with mechanical properties 
similar to gels prepared by natural extracellular matrix derived components such as 
collagen I (3).  
 
2.4 Tissue engineering still faces some challenges. 
In vivo, cells can move in 3D using either proteolytic (mesenchymal) or no proteolytic 
(amoeboid) strategies. During proteolytic migration, cells secrete proteases, which break 
down macromolecules of the ECM and thus create macroscopic cavities that allow their 
movement (1). This has been emulated in vitro in synthetic matrix gels by the 
incorporation of the mentioned MMP-sensitive cross linkers, such as GPQG-IAGQ. 
However, in vivo cells are able to dynamically reconstruct the ECM that is being 
digested. Emulation of this process in the PEG hydrogels is one of the major complex 
functionalities that tissue engineering is facing.  The goal of this work is to ameliorate 
this issue by finding short peptide sequences that could promote the reconstruction of the 
hydrogels networks in vitro (Figure 1) 
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 PEG 4MAL;    RGD;    Cross linkers;   metalloproteases;  7mer peptide;  
collagen  
 
Figure 1: Representation of candidate peptides working as crosslinkers in a synthetic PEG hydrogel. 
This is a representation of the main aim of this work; used here as example the potential use of 7mer 
peptides with collagen affinity as nucleation seeds in the construction of PEG-4MAL hydrogels.  A) Cells 
in a 3D PEG-4MAL hydrogel. B-D) Matrix-cell dynamic interaction zone augmented. B) Cells attach to the 
gel by the interaction of an integrin with the cell-anchorage tripeptide RGD (grey); also, cell-secreted 
MMPs targeting crosslinkers (purple). C) Cell produces and secretes collagen, which is captured by a 7mer 
peptide nearby. D) Collagen molecules and 7mer peptides promote the formation of collagen fibrils. (Note: 
this is a representation; it is not at scale; the pathways and processes shown here such as the collagen 
synthesis are incomplete) 
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CHAPTER 3 
INNOVATIVE GENERATION OF SELF-HELING HYDROGELS  
 
3.1 Innovation: 
The innovative feature of this work is the generation of “self-healing” PEG hydrogels: 
gels that could imitate the ECM reconstruction process that occurs in vivo. Finding 
molecules that could work as re-connectors or as ECM polymer nucleation points in 3D 
synthetic gels could increase the use of these PEG-based hydrogels as a model system for 
studies in tissue engineering, regenerative medicine, and as models of pathophysiology.  
This new feature will allow us to study morphogenic phenomena, such as metastasis, in a 
scenario that recapitulates the in vivo scenario with the advantage of a controllable and 
reproducible system.  
 
3.2 Rationale: 
In vivo, weak interactions such as van der Waals, electrostatic, hydrogen bonding and 
hydrophobic repulsions are responsible for the assembly and architecture of 
supramolecular structures such as the ECM.  However, these interactions are not 
established randomly. The exquisite and highly specific recognition ability of 
biomolecules is the key to weak interactions constructing the aforementioned super 
structures. In nature, this selective recognition ability of biomolecules is the result of ages 
of evolution.  
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In vitro, a powerful tool to seek specific recognition ability is phage display; a method to 
identify new peptides with selective affinity for certain molecules screened from 
bioengineered peptide libraries displayed on phage surfaces. Given their regular structure, 
these peptides might recognize superficial organization of functional groups of the target 
molecules, which imbue these peptides with specific affinities. Such affinities give them 
the potential to facilitate patterning or as catalysts for assembling target molecules into 
more complex structures (11). Because the phage display peptide library represents every 
possible peptide composed of seven amino acids (20
7
 peptides), presumably it would 
feature all the potential physical characteristics and affinities possible, some of those will 
likely possess affinity to our interest molecules: collagen and fibronectin.  In this way I 
will identify and isolate short peptides with binding properties to collagen and fibronectin 
to re-connect or serve as nucleation points when added to a PEG-based hydrogel 
containing collagen, fibronectin or both.  This approach could be rationally extended to 
any other target protein of interest. 
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CHAPTER 4 
AIM 1: USE PHAGE DISPLAY TO IDENTIFY PEPTIDE CANDIDATES THAT 
BIND TO EITHER COLLAGEN I OR FIBRONECTIN. 
 
4.1 Hypothesis:  
By phage display I will find peptides able to bind to fibronectin or collagen for eventual 
use in PEG-based hydrogels. 
A phage display is a library of random oligopeptides expressed on an M13 phage virion 
with the DNA encoding each peptide on the inside (12).  This approach allows 
identification of a phenotype and a genotype with a relatively simple screening step. This 
screening process is called panning, and can distinguish variants of the peptides based on 
their differential affinity to a target molecule. The phage display protocol consists of four 
crucial steps: 1) coating a plate with the target molecule; 2) challenging the target with 
the phage library; 3) washing the weak-binding phages away; and 4) eluting phages of 
interest and amplification. Then, the whole process is repeated again to increase the mass 
of the phage of interest and select the more specific ones to be sequenced (Figure 2). 
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Figure 2: Phage Display Technique. 1) Coating a plate with the target molecule, in this case it is shown 
collagen as example; 2) Challenging the target with a phage library; 3) Washing the weak-binding phages 
away and selecting the phage of interest; 4) Eluting the interest phage and amplifying it; 5) Repeat two or 
three cycles; 6) Consensus peptide sequence, the 7mer. 
 
 
4.2 Method: 
4.2.1 Direct target coating: 
The most straightforward way to carry out the panning process is by directly coating a 
plastic plate with the molecule target. 
1. Following the New England BioLabs’ Phage Display Ph.D 7 kit manual 
recommendations (NEB#E8100) a 100 μg/ml solution of Fibronectin in 0.1 M NaHCO3, 
pH 8.6 and a collagen solution at the same concentration in the same solvent were 
prepared as coating buffers.  
2. Then 1.5 ml of each was individually added by separately to two wells of two six well 
plates each (one for fibronectin and the other for collagen), swirled  and incubated 
overnight at 4°C with gentle agitation in a humidified container, one for each plate.  
3. Following the subsequent steps recommended by the manufacturer in the NEB#E8100 
manual for the panning process, the coating solutions were poured off from each plate, 
replaced by Blocking Buffer (0.1 M NaHCO3 pH 8.6, 5 mg/ml BSA), incubated by an 
1 2 3 
4 
5 
6 Collagen coated 
plates 
collagen 
M13 phages with 
peptide library 
7mer peptides 
Phage expressing 
7mer with high 
affinity to collagen 
2 rounds of amplification 
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binding 
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sequence 
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hour at 4°C, discarded, and each well was washed 6 times with TBST (TBS + 0.1% [v/v] 
Tween-20). 
4. A 100-fold dilution of the library was prepared by diluting 10 µl of the peptide library 
with 1 ml of TBST, pipetted onto coated plate, rocked gently for 60 minutes at room 
temperature and discarded nonbinding phage by pouring off and slapping plate face-
down onto a clean paper towel. 
5. The wells were washed 10 times with TBST 0.1% (Tween 20 0.1 %) and slapped 
down on a clean section of paper towel each time to prevent cross-contamination. 
6. The bound phage was eluted with 1 ml of 0.2 M Glycine-HCl (pH 2.2), 1 mg/ml BSA 
(a general buffer for nonspecific disruption of binding interactions). The elution mixture 
was rocked gently for 15 minutes at room temperature, then pipetted into a 
microcentrifuge tube, and neutralized with 150 μl of 1 M Tris-HCl, pH 9.1. 
7. Finally, 1 μl of each eluate was diluted 10, 102 and 103 folds in LB and tittered by a 
plaque assay method. For this, aliquots of 200 µl of E. coli ER2738 cultured in LB until 
mid-log phase (OD600= 0.5) one for each dilution, were infected with the phage dilutions 
mentioned above. They were incubated for 5 minutes, introduced separately in aliquots of 
3 ml of top agar at 45°C and plated on pre-warmed LB/IPTG/Xgal plates. We expected to 
count blue plaques (that represent the amount of phage) after incubation at 37°C for 48 
hrs. Because the peptide library is constructed on a M13KE cloning vector, which carries 
the lacZα gene, phage plaque appear blue when plated on media containing Xgal and 
IPTG. 
After the 48 hrs of incubation at 37°C, a single blue plaque was observed. 
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4.2.2. Optimized Coating conditions: 
 
8. To find the conditions under which this system is optimized, the above process was 
repeated using different buffers and concentrations. In step 1, the concentration chosen 
for the coating protein collagen was 50 µg/ml based on the NEB #E8100 protocol (10µg-
100 µg/ml) and 1µg/cm
2
 based on standard coating protocols, which recommend this 
concentration in order to ensure that these proteins would not form fibers.  The buffers 
chosen, shown in Table 1, were selected based on the NEB #E8100 Manual, standard 
protocols and from literature (see references 12 and 15). Based on the same literature for 
the conditions 3 to 8, collagen was dissolved in acetic acid 0.2M at 1 µg/µl concentration 
previous to dissolved again in the coating buffer. All panning processes were carried out 
in six well plastic culture plates. Table 1 shows the coating buffers used for collagen and 
Table 2 for fibronectin.   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 1: Collagen Coating Buffers 
 Collagen: 
1 25 µl + 1.5 ml NaHCO3  0.1M 
2 9.5 µl + 1.5 ml NaHCO3  0.1M 
3 75 µl in AcACH 0.2M +  1.5 ml NaHCO3 
4 9.5 µl in AcACH 0.2M +  1.5 ml NaHCO3 
5 75 µl in AcACH + 1.5 ml  35mM NaHCO3/Na2CO3 15mM 
6 9.5 µl in AcACH + 1.5 ml  35mM NaHCO3/Na2CO3 15mM 
7 75 µl in AcACH + 1.5 ml TBS 
8 9.5 µl in AcACH + 1.5 ml TBS 
 
 
Table2: Fibronectin Coating Buffers 
 Fibronectin: 
1 9.5 ul +  1.5 ml NaHCO3 
2 9.5 + 1.5 ml  35mM NaHCO3/Na2CO3 15mM 
3 15 ul in AcACH + 1.5 ml TBS 
13 
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4.2.3 Washing curve: 
9. In order to find whether the washes in step 5 of Section 1A (involving 10 washes with 
TBST 0.1 %) were excessive and the phages of interest were being washed away, a 
washing curve was performed. Six single wells of a six well plate were prepared for each 
one of the conditions detailed in the Tables 1 and 2 and labeled from A to F. In step 5, 
instead of a single step of 10 washes with TBST 0.1%, a series of different washes were 
carried out separately. These washing series were, those wells labeled A were washed 2 
times; those labeled B were treated with 3 washes; C with 4; D were 6, E with 8 and F 
with 10 washes. 
10. After the washing steps, the bound phage were eluted with 1 ml of 0.2 M Glycine-
HCl (pH 2.2), 1 mg/ml BSA rocking them gently by 15 minutes at room temperature, 
then pipetted into microcentrifuge tubes, and neutralized with 150 μl of 1 M Tris-HCl, 
pH 9.1. 
Finally, 1 μl of each eluate was diluted 10, 102 and 103 fold in LB and tittered by the 
plaque assay method as described in Section 1A step 7. 
11. From the plates of collagen, binding phages eluted from coating buffer condition 4 
(9.5 µl in AcACH 0.2M + 1.5 ml NaHCO3) washed six and eight times, were counted; 30 
blue plaques in each plate at 10
3
 plating dilution. From the plates of fibronectin binding 
phages eluted from coating buffer condition 1 (9.5 µl + 1.5 ml NaHCO3) were washed six 
and three times were counted; about 70 blue plaques in each plate at 10
3
 plating dilution. 
The plaques count fell by half with eight washes. 
14 
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12. The eluted phages from these two conditions treated with six washes were amplified 
by adding the eluate to 20-ml ER2738 cultures (one for each condition) at early-log 
(OD600~ 0.01-0.05) and incubating at 37°C and 250 rpm during 4.5 hours . 
13. Cultures were transferred to individual centrifuge tubes and spun for 10 minutes at 
12,000 g at 4°C. The supernatants were transferred to fresh tubes and re-spun. 
14. The upper 80% of the supernatants (16 ml) were transferred to fresh tubes and 4 ml of 
20% PEG/2.5 M NaCl was added to each tube, then left overnight to precipitate at 4°C . 
15.  The tubes were spun at 12,000 g for 15 minutes at 4°C, supernatants discarded, tubes 
re-spun briefly, and residual supernatants removed with a pipette.  
16. Phage pellets were suspended in 1 ml of TBS each one, transferred to individual 
microcentrifuge tubes and spun at 14,000 rpm for 5 minutes to pellet residual cells. 
17. The supernatant was transferred to individual microcentrifuge tubes and re-
precipitated by adding 1/6 volume of 20% PEG/2.5 M NaCl. Then, they were incubated 
on ice for 60 minutes. They were centrifuged at 14,000 rpm for 10 minutes, the 
supernatants were discarded, re-spun, and any residual supernatant was removed with a 
micropipet. 
18. Pellets were suspended in 200 μl of TBS, centrifuged for 1 minute to pellet any 
remaining insoluble material and the supernatant was transferred to individual tubes. 
These are the amplified eluates with which a second panning process was carried out. 
 
4.2.4 Second Panning 
19. A second panning process was carried out following the above procedure with few 
slight modifications. 
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In step 1 of the process described in Section 1A, a six well plate was coated with collagen 
using the coating conditions shown in Table 3 in triplicate.  Similarly, another plate was 
coated with fibronectin using the coating conditions shown in Table 4 in triplicate. 
 
 
20. 10 µl of each eluate was diluted with 1 ml of TBST and pipetted onto a coated plate. 
The phages eluted from a fibronectin coated plate in the first panning were pipetted onto 
a fibronectin coated plate. The process was repeated for phages eluted from collagen 
coated plates. These plates were rocked gently for 60 minutes at room temperature and 
nonbinding phage discarded by pouring off and slapping plate face-down onto a clean 
paper towel. 
21. In order to remove any weakly bound phages, the plates were washed as described 
above in step 5 of Section C1, but using TBST 0.5 % (Tween20 0.5%). The wells were 
coated in triplicate in order to carry out three different washing series. One well of each 
series was washed 3 times, another 6 and the last 8 times. 
22. After the elution of the phages and tittering as described above in Section C, 5 blue 
plaques were observed on the plate inoculated with fibronectin binding phages eluted 
from coating condition 1 treated with six washes at plating dilution 10
3
; also 2 blue 
Table 3: Second Panning 
 Collagen Coating Buffers 
 Collagen: 
1 75 µl in AcACH 0.2M +  1.5 ml NaHCO3 
2 9.5 µl in AcACH + 1.5 ml  35mM  
NaHCO3/Na2CO3 15mM 
Table 4: Second Panning 
 Fibronectin Coating Buffers 
 Fibronectin: 
1 9.5 µl +  1.5 ml NaHCO3 
2 9.5 + 1.5 ml  35mM NaHCO3/Na2CO3 15mM 
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plaques from collagen binding phages from coating condition 2 treated with six washes at 
plating dilution 10
3
 (Figure 3). 
 
Figure 3 
 
       
 
 
 
 
 
 
 
  
 
 
4.2.5 Phage amplification / phage stock preparation: 
Because of dilution, each single isolated blue plaque obtained should to correspond to a 
single phage clone. These were amplified by inoculation of E. coli ER2738 culture.  
1. An overnight culture of ER2738 was diluted 1:100 in LB and aliquot into eight culture 
tubes by 1 ml each. 
2. Using a sterile wooden stick each single blue plaque from the tittering plates was 
stabbed and transfer to a single tube containing the diluted culture. Having well 
separated, isolated plaques increases the chances that each plaque contains a single DNA 
sequence. 
3. The tubes were spun at 37°C and 250 rpm for 4.5 minutes. 
4. The cultures were transferred to microcentrifuge tubes, and spun at 14,000 rpm for 30 
seconds. The supernatants were transferred to fresh tubes and re-spun. Then the upper 
80% of the supernatants (800 µl each) were transferred to fresh tubes. These are the 
amplified phage stock. 
A B 
Figure 3: Collagen 
and fibronectin phage 
titering. A) Xgal/IPTG 
LB plate showing two 
blue plaques form a 
collagen binding phage 
tittering diluted 10
3
. 
 B) Xgal/IPTG plate 
from fibronectin 
binding phage at same 
dilution 
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4.2.6 Phage DNA purification and sequencing: 
The DNA of each phage clone was purified using the E.Z.N.A M13 DNA Mini Kit from 
Omega Bio-tek (D6900-01) following the manufacturer’s recommendations. This kit is 
designed to purify single-stranded DNA from phage supernatant. 
The isolated DNA samples were sequenced by GENEWIZ sequencing service by Sanger 
sequencing using the sequencing primer -96 gIII : 5´- HOCCC TCA TAG TTA GCG 
TAA CG –3´ 
Resulting in the following consensus sequences: 
Fibronectin: 
>NNNNNNNNNNNNNNNNANNNNNNNNCNNNGTTANNNNTGAATTTTCTGTATGGGATTTTGCTAAACAACTTTCAACAGTT 
TCGGCCGAACCTCCACCAAAAGACCACTTCGACAAACTAGAGTGAGAATAGAAAGGTACCACTAAAGGAATTGCGAATAA 
TAATTTTTTCACGTTGAAAATCTCCAAAAAAAAGGCTCCAAAAGGAGCCTTTAATTGTATCGGTTTATCAGCTTGCTTTC 
GAGGTGAATTTCTTAAACAGCTTGATACCGATAGTTGCGCCGACAATGACAACAACCATCGCCCACGCATAACCGATATA 
TTCGGTCGCTGAGGCTTGCAGGGAGTTAAAGGCCGCTTTTGCGGGATCGTCACCCTCAGCAGCGAAAGACAGCATCGGAA 
CGAGGGTAGCAACGGCTACAGAGGCTTTGAGGACTAAAGACTTTTTCATGAGGAAGTTTCCATTAAACGGGTAAAATACG 
TAATGCCACTACGAAGGCACCAACCTAAAACGAAAGAGGCAAAAGAATACACTAAAACACTCATCTTTGACCCCCAGCGA 
TTATACCAAGCGCGAAACAAAGTACAACGGAGATTTGTATCATCGCCTGATAAATTGTGTCGAAATCCGCGACCTGCTCC 
ATGTTACTTANCCGGAACGAGGCGCANACGGTCAATCATAAGGGAACCGAACTGACCAACTTTGANAGAGGACAGATGAA 
CGGTGTACAGACCANGCGCATANGCTGGCTGACCTTCATCAAGANTAATCTTGACAAGAACCGGATATTCNTTACCCANA 
TCAACGTAACANAGCTGCTCATTCAGTGAATAANGCTTGCCCTGACGAGAAACACCANAACGANNAGTAAATTGGGCTTG 
ANATGGTTTAATTTCAACTTTAATCATTGTGAATTACNTTATGCGATTTTAAGAACTGGGCTCATTATACCAGTCNNGAC 
GTTGGGGANGAAAAATCTACNNNNATAAAACCGAANNNNCGGAACACNNTTATTACCANGNAGNAANNANTCATCNGTTT 
GANATTTNGGGAATACCNNNTNNNNNCTAANGNNNNN 
 
 
Collagen: 
> NNNNNNNNNNNNNNNNNNNNNNNCNNNNNCGACGTTAGTNNNTGAATTTNCNGNATGGGATTTTGCTAAACAACTTTCAA 
CAGTTTCGGNCGNNNNTNCACCATGAAGCTCCGACAGCGACCAAGAGTGAGAATAGAAAGGTACCACTAAAGGAATTGCG 
AATAATAATTTTTTCACGTTGAAAATCTCCAAAAAAAAGGCTCCAAAAGGAGCCTTTAATTGTATCGGTTTATCAGCTTG 
CTTTCGAGGTGAATTTCTTAAACAGCTTGATACCGATAGTTGCGCCGACAATGACAACAACCATCGCCCACGCATAACCG 
ATATATTCGGTCGCTGAGGCTTGCAGGGAGTTAAAGGCCGCTTTTGCGGGATCGTCACCCTCAGCAGCGAAAGACAGCAT 
CGGAACGAGGGTAGCAACGGCTACAGAGGCTTTGAGGACTAAAGACTTTTTCATGAGGAAGTTTCCATTAAACGGGTAAA 
ATACGTAATGCCACTACGAAGGCACCAACCTAAAACGAAAGAGGCAAAAGAATACACTAAAACACTCATCTTTGACCCTC 
AGCGATTATACCAAGCGCGAAACAAAGTACAACGGAGATTTGTATCATCGCCTGATAAATTGTGTCGAAATCCGCGACCT 
GCTCCATGTTACTTAGCCGGAACGAGGCGCANACGGTCAATCATAAGGGAACCGAACTGACCAACTTTGAAAGAGGACAG 
ATGAAACGGTGTACAGACCAGGCGCATANGCTGGCTGACCTTCATCAAGAGTAATCTTGACNAGAACCGGATATTCATTA 
CCCAAATCAACGTAACAAAGCTGCTCATTCANTGAATAAAGGCTTGCCCTGACNAGAAAACACCANAACGAGTNNNNAAA 
TTGGGGCTTTGANATGGTTTAATTTTCAACTTTNATCATNGTGAATTACNTNTNNNGCNANNN 
 
A bioinformatics analysis of the obtained DNA sequences by using NCBI BLAST tool 
(16) confirmed the position of the indel mismatch (peptide engineered library) at the N 
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terminal of the pIII gene of the phage M13 (See reference 14) where it is expected to be 
(Figures 4 and 6). Finally, by using the blastx tool of NCBI website(17), the sequences 
peptide sequences were obtained (Figure 5 and 7). 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
4.2.7 Conclusions of Aim 1:  
The sequence of the 7mer isolated from the collagen binding phages is WSLSELH and 
the sequence of the 7mer isolated from fibronectin binding phages is SLSKWSF. 
 
Figure 4:  Fibronectin binding phage BLAST. Alignment of a 
section of the sequence obtained from the isolated fibronectin 
binding phages (query) and a section of the phage M13 genome 
corresponding to the pIII gene 
Figure 5: Fibronectin Blastx. 
Peptide sequence obtained by blastx 
for fibronectin binding 7mer.  
Figure 6:  Collagen binding phage BLAST. Alignment of a 
section of the sequence obtained from the isolated collagen 
binding phages (query) and a section of the phage M13 
genome corresponding to the pIII gene 
 
Figure 7: Collagen blastx. Peptide 
sequence obtained by blastx for 
collagen binding 7mer.  
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CHAPTER 5 
AIM 2: SYNTHETIZE, CONFIRM, AND PURIFY CANDIDATE PEPTIDES. 
 
5.1 Hypothesis: 
We will successfully synthetize peptides identified in Aim 1 (Chapter 4) 
 
5.2 Method:   
We synthetized the peptides identifies in Aim1 as well as two peptides found in literature, 
one reported to bind to fibronectin, GLAGQRGIVGLPGQRGER (6) and the other 
reported to bind to collagen, AAHEEICTTNEGVM (7).  
Peptides were synthesized by solid-phase method by using a 9-
fluorenylmethyloxycarbonyl (Fmoc) strategy. The peptide chains were assembled on a 
Rink amide MBHA resin, which results in amino termini on both ends of the peptide. For 
coupling, N,N-diisopropylethylamine (DIEA) was used, as well as oxyma for coupling, 
and piperidine for Fmoc removal. All of the reactions were performed using 
dimethylformamide (DMF) as a solvent. To cleave the peptide from the resin and remove 
the side chain protecting groups, the peptide resin was treated with trifluoroacetic acid 
(TFA), triisopropylsilane and water.  The peptides were identified satisfactorily by 
matrix-assisted laser desorption ionization time-of-flight mass spectrometry 
(MALDITOF-MS).  
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CHAPTER 6 
AIM 3: TEST THE POTENTIAL APPLICATIONS OF THE ISOLATED 
PEPTIDES AS RE-LINKERS IN SYNTHETIC 3D MATRICES. 
 
6.1 Hypothesis:  
The affinity of the peptides obtained in Aim 1 (Chapter 4) and synthesized in Aim 2 
(Chapter 5) for collagen and fibronectin are requirement enough for these peptides 
function as re-linkers or nucleation points. 
 
6.2 Method:  
As mentioned in the significance section, PEG-4MAL is a very useful tool in 
mechanobiology and tissue engineering because of its efficiency on incorporating the 
metalloproteases degradable cross linkers and RGD, its gelation time and tight structure. 
Moreover, with PEG-4MAL gels can be prepared with mechanical properties that mimic 
those of ECM derived components. Thus, we are interested to try whether we could 
improve PEG-4MAL properties by adding the peptides synthesized in Aim 2. We expect, 
these peptides could function as “nucleation seeds” promoting the building up of ECM 
elements on the hydrogels. In this way, this de novo building up of ECM elements could 
restore the gel’s stiffness, which is weakened by the protein digestion occurring during 
cell migration. We will prepare PEG-4MAL hydrogels following standard protocols with 
a slight modification. The peptides will be diluted separately in DMSO at 1mM 
concentration and added to a 2 mM RGD solution.  Gels will then be prepared as 
described in the attached protocol and the peptide-RGD solution will be mixed with 
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PEG-4MAL at a ratio of 1:100 RGD-peptide:PEG-4MAL.  Cells will be seeded on the 
gels and after 7 days will be fixed with 4% formaldehyde and ECM components detected 
by immunostaining and fluorescent images taken using imageJ. 
Thomas McCarthy, a Peyton Lab member, had carried out a first attempt to this 
experiment using a modified version of the peptides sequenced in Aim1 and a 
mesenchymal stem cell h-Tert cell line (no further specifications on the cell line used). 
These peptides, also synthesized in Aim2, were CWSLSELHC for collagen and 
CSLSKWSFC for fibronectin. Cell were labeled with mouse anti-collagen type 1  
(MAB3391 Millipore) and TRITC conjugated anti-mouse secondary antibody (RED) 
(non specified); DAPI to stain the nuclei (blue) and alexa fluor 488 conjugated mouse 
anti-fibronectin (563100, BD Pharmingen, green). On this experiment, it has not been 
observedbuilding up of ECM elements on the matrix gels  (Figure 8), suggesting that 
these peptides did not serve as nucleation point. However, this experiment should be 
repeated and optimized to fully explore the potential of de novo nucleation points. 
 
Figure 8: 
Immunofluorescent assay. 
Fluorescent immunostaining 
to analyze ECM elements 
building up in PEG-4MAL 
gel prepared with short 
peptides. Pictures have been 
taken with imageJ.  No ECM 
elements observed on gel. 
Courtesy of Thomas 
McCarthy. 
 
22 
30 
 
CHAPTER 7 
 
PROJECTIONS ON SHORT PEPTIDES AS ECM ELEMENTS’ NUCLEATION 
POINTS/CROSSLINKERS 
7.1 Potential Pitfalls: 
The short peptides might not bind to the target molecules with the same strength that the 
respective phages they are derived from do or may not bind to the target molecules when 
they are free from the phage structure. It has been demonstrated that the interaction of the 
free peptides with the target molecules is significantly weaker than their phage 
counterparts (13). This could be the result of a synergy of the affinity of the five peptide 
copy on the phage coat results in an enhanced affinity when they are attached to it. 
Another reason could be that the conformation and orientation of the peptides are crucial 
to their affinity, or when they are free from the phage, their affinity to other copies of the 
same peptide is higher than the affinity to the target protein. 
 
7.2 Potential solutions: 
A practical way to check whether the peptides are capable of binding to their target 
molecules is by ELISA assay. Cover slips should be coated with the peptides, and then 
they should be challenged by the target molecules and finally using antibodies against the 
target molecules to verify their interaction.  
In case the peptides do not bind to the target molecules, a structure could be constructed 
that mimics the phage structure. In this way the peptides would conserve their 
tridimensional orientation (13).  
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7.3 Future Directions: 
As a short term future direction the ELISA assays proposed above should be carried out. 
Also, the testing of the peptides on the hydrogels described in aim 3 should be completed. 
Once the function of the aforementioned peptides is confirmed, their applications in 
different hydrogel systems such as PEG-PC (phosphorylcholine) should be explored. 
Also, their potential applications in drug testing may be assessed; for example to detect 
an inhibitor of ECM building up or metalloproteases inhibitors. Another potential 
application is tissue engineering, to explore how these peptides could contribute to the 
rebuilding or healing of tissues using synthetic scaffolds. In case these peptides do not 
function as proposed, a future direction would be the construction of structures that 
mimic the phage structure as proposed on the previous section. 
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APPENDIX A: 
 
 
PEG-MAL HYDROGEL PROTOCOL 
Materials: 
4-arm Polyethylene glycol-maleimide (PEG- 4MAL), MW 20 kDa, >95% purity (JenKem) cross-
linking polymer 
 Pan-MMP (degradable) sequence: GCRDQGWI↓GQPGDRCG (GenScript). 
o Note: Other degradable sequences can be made for specific MMPs. 
o J, Patterson, JA Hubbell, Biomaterials 31 (2010) p.7836-7845 
o Generally, these peptides are purchased in aliquots of 0.5 mg to avoid weighing 
errors. 
 Linear PEG dithiol, MW 1.5kDa, >95% purity (JenKem or Sigma) 
Adhesive ligand   
 RGD sequence: RGDC, >95% purity (GenScript) 
 Note: other adhesive ligands can be added to the gel. 
PBS, pH 7.4  
200 mM Triethanolamine (TEOA) in PBS, pH 7.4 
 
Gel making protocol:  
1. Gels are calculated by weight percent. Crosslinking is determined by matching moles of 
crosslinker to moles of PEG-MAL.  
2. Warm polymer solutions to room temperature and weigh out appropriate mass of 
polymers needed. 
3. Make 200 mM TEA in PBS, pH 7.4 (maleimide-thiol reaction only occurs at pH 7-7.5). 
4. Dissolve crosslinking polymers in sterile TEOA solution and PEG-MAL in PBS. 
5. Functionalize hydrogel. 
a. Mix PEG-MAL and RGD at 100:1 ratio. 
b. React at room temperature for 30 min. 
6. If encapsulating cells, begin to split the cells and spin down the desired cell amount into a 
pellet. 
7. Re-suspend cell pellet in the PEG-RGD solution. Minimize the time cells spend in un-
crosslinked PEG solution. 
8. Cast hydrogels by mixing PEG-RGD-cells with crosslinking solution at 10:1 ratio. 
a. Note: Gels polymerize quickly.  
9. Incubate gel at 37°C ~15minutes or until fully gelled. 
10. Add media (or PBS if no cells) to swell gel. 
 
Notes: 
TEOA 
 Higher TEOA concentrations may be used to decrease reaction time and increase reaction 
rate.  
 Maleimide-thiol reaction occurs at pH range in between 7 and 7.5. Bring the pH to 7.4 
when encapsulating cells. 
PEG-MAL 
 Should be stored with nitrogen gas at -20°C in a sealed container.  
Peptides 
 Should be stored at -20°C. 
 Each adhesive ligand will affect the gelation process differently and must be 
experimented with. Check the pH of the solution if you have gelation problems. 
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APPENDIX B: 
 
NOTES: 
 
Thomas McCarthy, a Peyton Lab member, had carried out the experiment explained in 
chapter 6 using a modified version of the peptides sequenced in Aim1 (Chapter 4) and a 
mesenchymal stem cell h-Tert cell line (no further specifications on the cell line used). 
Thomas McCarthy has also provided the figure 8 corresponding to mentioned 
experiment.   
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